Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Current Drug Therapy

Reducing the risks when using benzodiazepines to treat insomnia: A public health approach

Vania Modesto-Lowe, MD, MPH, Margaret M. Chaplin, MD, Roberto León-Barriera, MD and Lakshit Jain, MD
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: https://doi.org/10.3949/ccjm.91a.23061
Vania Modesto-Lowe
Department of Psychiatry, University of Connecticut, Farmington, CT; Medical Director, Hartford Behavioral Health, Hartford, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret M. Chaplin
Department of Psychiatry, University of Connecticut, Farmington, CT; Farrell Treatment Center, New Britain, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto León-Barriera
Assistant Professor, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshit Jain
Assistant Clinical Professor, Department of Psychiatry, University of Connecticut, Farmington, CT; Connecticut Valley Hospital, Middletown, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Alternatives to formal cognitive behavioral therapy for insomnia

    Online apps and self-help books
    Online resources include books patients can read on their own and apps that guide patients through cognitive behavioral therapy for insomnia
    Brief therapies for insomnia
    Abridged versions of cognitive behavioral therapy that emphasize behavioral aspects of sleep regulation
    Education is given on sleep hygiene, factors that affect sleep, and principles of sleep restriction (described below)
    After examining a sleep diary, primary care clinicians can inquire about the patient’s sleep habits and provide education on patient-specific factors that may be affecting sleep (eg, excess alcohol, using screens in bed, attempting to go to bed too early)
    Sleep-restriction therapy
    Aims to limit a patient’s time in bed to when asleep
    Patients are asked to limit their time in bed to their average sleep time, go to bed only when sleepy, get up if they cannot fall asleep, and return to bed only once sleepy: the idea is that most of the time spent in bed is sleeping
    Gradually the time spent in bed is increased as sleep duration and quality improve
    Stimulus control
    The idea is to extinguish the association between the bed and wakefulness
    Patients should be instructed to use the bed only for sleep and sex, establish a consistent bedtime and waking time, go to bed only when sleepy, get out of bed if unable to sleep, and refrain from daytime naps
    Relaxation therapies
    Includes exercises designed to decrease tension, eg, deep breathing, abdominal breathing, progressive muscle relaxation, and meditation
    A variety of applications can be used for guided meditation and relaxation
    • Based on information in references 5, 12, and 18.

    • View popup
    TABLE 2

    Strategies and tips for tapering benzodiazepines

    Strategies
    Taper by 25% every 2 weeks
    If dosage forms do not allow for a 25% reduction, consider a 50% reduction
    Consider slowing to 12.5% for the final 2 weeks of the taper
    Consider alternate-day dosing for the final 2 weeks of the taper
    Tips
    Educate patients on what to expect and reassure them that symptoms will resolve
    Consider switching to a medication formulation with lower dose options
    Consider using a nonaddictive medication alternative
    Some patients may require an extremely slow taper—over months, not weeks
    • Based on information in reference 5.

    • View popup
    TABLE 3

    Preventing harm from benzodiazepines

    Primary prevention15
    Educate the public about benzodiazepine harms
    Educate prescribers and patients about cognitive behavioral therapy for insomnia
    Educate patients about risks of falls, fractures, and addictive potential
    Limit use to a carefully selected population
    Set the stage for limiting use to less than 4 weeks
    Secondary prevention13,22
    Taper after 4 weeks
    Use behavioral interventions, letters, brochures, or face-to-face interventions to encourage patients resistant to intervention
    Educate prescribers about the need to discontinue benzodiazepines
    Tertiary prevention5,11
    Use motivational interviewing to evaluate the stage of change
    Use shared decision-making to discuss risks and benefits to help move the patient to the action level of change
    Optimize deprescribing by addressing rebound (through education), withdrawal (through gradual tapering), and relapse (through addition of psychological support)
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (5)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 5
1 May 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
Vania Modesto-Lowe, Margaret M. Chaplin, Roberto León-Barriera, Lakshit Jain
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: 10.3949/ccjm.91a.23061

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
Vania Modesto-Lowe, Margaret M. Chaplin, Roberto León-Barriera, Lakshit Jain
Cleveland Clinic Journal of Medicine May 2024, 91 (5) 293-299; DOI: 10.3949/ccjm.91a.23061
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • A PUBLIC HEALTH APPROACH
    • PRIMARY PREVENTION: PRESCRIBE BENZODIAZEPINES JUDICIOUSLY
    • SECONDARY PREVENTION: KEEP THE DURATION OF USE SHORT
    • TERTIARY PREVENTION: STOPPING AFTER LONG-TERM USE
    • CONCLUSION
    • DISCLOSURES
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Nonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomes
  • A practical guide for buprenorphine initiation in the primary care setting
Show more Current Drug Therapy

Similar Articles

Subjects

  • Drug Therapy
  • Mental Health
  • Sleep Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire